Evra transdermal patch 3 Patches

Evra transdermal patch 3 Patches is intended for women of fertile age. The safety and efficacy has been established in women aged 18 to 45 years.It is the best product for Pregnancy prevention. The decision to prescribe EVRA should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with EVRA compares with other CHCs